Logo

Microsatellite Instability Testing

The latest news on microsatellite instability testing.

Promega, Henlius to Develop Microsatellite Instability CDx for Cancer Drug

The companies aim to develop the companion diagnostic for use with Henlius' investigational treatment for microsatellite instability-high solid tumors.

Biocartis Files FDA Submission for Microsatellite Instability Test in Colorectal Cancer

The assay is intended to detect

Dana Farber Team Applies PCR Method to ID Microsatellite Instability in Tumor-Derived Samples
Premium

The group aims to adapt the method, which detects poly-adenine tails, to monitor for minimal residual disease in late-stage colon cancer patients after surgery.

Researchers Aim to Improve Lynch Syndrome Testing With Genetic-Epigenetic Combination Method
Premium

The sequencing test involves a single library preparation that is then split for parallel analysis of promoter methylation, MSI calculation, and gene mutation detection.

Diagnostics Firms, Lab Providers Form Genomic Profiling Coalition

The new consortium is aiming to make comprehensive genomic profiling accessible to advanced cancer patients in the US, to help inform their treatment decisions.

Oct 16, 2020

Disparity in Microsatellite Instability Testing Suggests Need to Close Socioeconomic Access Gaps
Premium

Sep 22, 2020

Promega to Develop MSI Assay as CDx for Incyte Endometrial Cancer Drug

Jul 21, 2020

NCCN's Updated Inherited Colorectal Cancer Risk Guidelines Features Gene-Specific Information

Jun 9, 2020

Promega Nabs CE Mark for Microsatellite Instability IVD

May 5, 2020

Bayer, NeoGenomics Launch Free NTRK Fusion Testing Program

Apr 14, 2020

Merck Bid for Second Pan-Cancer Keytruda Indication Would Raise Tumor Mutation Burden to CDx Status
Premium

Mar 5, 2020

Biocartis Reports 35 Percent 2019 Revenue Rise, New Bristol-Myers Squibb CDx Project

Feb 19, 2020

Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing

Feb 12, 2020

Exact Sciences Boosting Position in Cancer Dx Market Through M&A
Premium

Jan 27, 2020

Colon Cancer Biomarker Undertesting Rates in Real-World Data Points to Precision Oncology Barriers
Premium

Dec 17, 2019

NeoGenomics Focused on Companion Diagnostics, NGS in 2020
Premium

Nov 7, 2019

Colorectal Cancers Dial up Mutability in Response to Targeted Treatments

Nov 6, 2019

Merck, Promega Collaborate to Develop MSI CDx for Keytruda

Oct 24, 2019

Calviri to Develop Checkpoint Inhibitor Response Prediction Test Under $300K NCI Grant

Sep 23, 2019

PGDx Shares New MSI Data, Provides Update on FDA Bid for Pan-Cancer IVDs
Premium

Aug 8, 2019

Guardant Health Preps Pan-Cancer FDA Bid, Highlights New MSI Validation Data
Premium

May 16, 2019

NCI Pediatric MATCH Trial Interim Data Shows 24 Percent of Patients Eligible for Targeted Therapy
Premium

May 2, 2019

Liquid Biopsy-Based Androgen Receptor Alterations Associated With Advanced Prostate Cancer Outcomes

Apr 9, 2019

Immunotherapy Developers, Clinical Researchers Continue to Seek New Dx Strategies
Premium

Mar 5, 2019

Biocartis Pushing Further Into Immunotherapy, Liquid Biopsy Space With Idylla Menu
Premium

Breaking News
The Scan

Blend of Omicron With Delta

The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant.

Limited Contrast

The New York Times reports that there is a shortage of a contrast agent used for some medical scans.

Pig Improvement

Farmers in China are using genetics to improve their hog herds, according to Reuters.

Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More

In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.